Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-18-028076

Director sold 30,824 shares at an average $111.83 ($3,446,909)

  • Director acquired 25,122 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GRANADILLO PEDRO P · Director

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2018-09-17 Exercise or conversion : show line 1 in the form +8,196 $36.37 $298,089 41,555 D
2018-09-17 Exercise or conversion : show line 2 in the form +6,573 $45.45 $298,743 48,128 D
2018-09-17 Exercise or conversion : show line 3 in the form +10,353 $35.50 $367,532 58,481 D
2018-09-17 Sale : show line 4 in the form −1,502 $108.92 $163,598 56,979 D
2018-09-17 Sale : show line 5 in the form −3,696 $110.11 $406,967 53,283 D
2018-09-17 Sale : show line 6 in the form −13,183 $111.33 $1,467,663 40,100 D
2018-09-17 Sale : show line 7 in the form −11,812 $113.16 $1,336,646 28,288 D
2018-09-17 Sale : show line 8 in the form −631 $114.16 $72,035 27,657 D
Open-market sales · 30,824 sh · avg $111.83 · $3,446,909

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2018-09-17 Exercise or conversion : show line 9 in the form Non-qualified Stock Option (Right to Buy) −8,196 0 D
2018-09-17 Exercise or conversion : show line 10 in the form Non-qualified Stock Option (Right to Buy) −6,573 0 D
2018-09-17 Exercise or conversion : show line 11 in the form Non-qualified Stock Option (Right to Buy) −10,353 0 D
Loading xslF345X03/form4.xml…